PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40651904,"In Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy, Dynamics of Circulating Tumor DNA Following Cystectomy: Association with Patient Outcomes.",2025-Jul-11,Frederike Fuhlbrück; Natasha Oza,"Signature Diagnostics GmbH, Potsdam, Germany.; Roche Molecular Systems, Inc, Pleasanton, CA, USA.",
40651599,Targeted delivery of therapeutics to metastatic lung cancer cells using aptamer-conjugated nanoemulsions.,2025-Jul-10,Maria Cristina Tarasco; Elvira Pantano; Giulia Taiè; Giulia Bertolini; Luca Roz,"Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.",
40651477,Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro.,2025-Jul-04,Fiorella Scagnoli; Federica Barbaglio; Daniela Belloni; Riccardo Pinos; Marta Sampietro; Margherita Pauri; Cristina Scielzo,"Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.; Division of Experimental Oncology, Malignant B Cells Biology and 3D Modelling Unit, IRCCS Ospedale San Raffaele, 20132 Milano, Italy. Electronic address: scielzo.cristina@hsr.it.",scielzo.cristina@hsr.it.
40651458,A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.,2025-Jul-11,Yan Zhou; Lijun Wei; Hui Wang; Jun Liu; Xiang Zhou; Ke Wang,"Changzhou Qianhong Biopharmaceuticals Co. Ltd., Xinbei District, Jiangsu 213125, China.; Changzhou Qianhong Biopharmaceuticals Co. Ltd., Xinbei District, Jiangsu 213125, China.; Changzhou LeSun Pharmaceuticals Ltd., Xinbei District, Jiangsu 213125, China.; Changzhou LeSun Pharmaceuticals Ltd., Xinbei District, Jiangsu 213125, China.; Changzhou Qianhong Biopharmaceuticals Co. Ltd., Xinbei District, Jiangsu 213125, China.; Changzhou Qianhong Biopharmaceuticals Co. Ltd., Xinbei District, Jiangsu 213125, China.",
